Abstract.
Shortened red cell life span and excess iron cause functional and physiological abnormalities in various organ systems in thalassemia patients. In an earlier study, we showed that β–thalassemia patients have a high prevalence of renal tubular abnormalities. The severity correlated with the degree of anemia, being least severe in patients on hypertransfusion and iron chelation therapy, suggesting that the damage might be caused by the anemia and increased oxidation induced by excess iron deposits. This study was designed to define the renal abnormalities associated with α–thalassemia and to correlate the renal findings with clinical parameters. Thirty-four pediatric patients (mean age 8.2±2.8 years) with Hb H disease or Hb H/Hb CS were studied. Ten patients (group 1) were splenectomized, with a mean duration post splenectomy of 3.5±1.4 years; 24 patients (group 2) had intact spleens. The results were compared with 15 normal children. Significantly higher levels of urine N-acetyl-β-d-glycosaminidase, malondialdehyde (MDA), and β2-microglobulin were found in both groups compared with normal children. An elevated urine protein/creatinine ratio was recorded in 60% of group 1 and 29% of group 2. Two patients (5.9%), 1 in each group, had generalized aminoaciduria. We found proximal tubular abnormalities in α–thalassemia patients. Increased oxidative stress, possibly iron induced, may play an important role, since urine MDA levels were significantly increased in both groups of patients.
Similar content being viewed by others
References
Winichagoon P, Thonglairuam V, Fucharoen S, Tanphaichitr VS, Wasi P (1988) Alpha–thalassemia in Thailand. Hemoglobin 12:485–498
Orkin SH, Nathan DG (1998) The thalassemias. In: Nathan DG, Orkin SH (eds) Nathan and Oski's hematology of infancy and childhood, 5th edn. Saunders, Philadelphia, pp 811–886
Sumboonnanonda A, Malasit P, Tanphaichitr VS, Ong-ajyooth S, Sunthomchart S, Pattanakitsakul S, Petrarat S, Assateerawatt A, Vongjirad A (1998) Renal tubular function in β–thalassemia. Pediatr Nephrol 12:280–283
Fucharoen S, Winichagoon P, Pootrakul P, Piankijgum A, Wasi P (1988) Differences between two types of Hb H disease, alpha–thalassemia1/alpha–thalassemia2 and alpha–thalassemia1/Hb Constant Spring. Birth Defects 23:309–315
Schwartz GJ, Haycock GB, Edelmann CM Jr, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263
Tanphaichitr VS, Mahasandana C, Suvatte V, Yodthong S, Pung–amritt P, Seeloem J (1995) Prevalence of hemoglobin E, alpha–thalassemia and glucose–6–phosphate dehydrogenase deficiency in 1,000 cord blood studies in Bangkok. Southeast Asian J Med Public Health 26 [Suppl 1]:271–274
Tanner JM, Whitehouse RH, Cameron N, Marshall WA, Healy MJR, Goldstein H (1990) Assessment of skeletal maturity and prediction of adult height (TW2 method), 2nd edn. Alden, Oxford
Moor JC, Moris JE (1982) A simple automated colorimetric method for determination of N–acetyl–β–d–glucosaminidase. Ann Clin Biochem 19:157–159
Efran ML, Young O, Moser HW, MacCready RA (1964) A simple chromatography screening test for the detection of disorder of amino acid metabolism. N Engl J Med 270:1378–1380
Knight JA, Smith SE, Kinder VE, Pieper RK (1988) Urinary lipoperoxides quantified by liquid chromatography and determination of reference values for adults. Clin Chem 34:1107–1110
Lim CW, Chisnall WN, Stokes YM, Debnam PM, Crooke MJ (1990) Effects of low and high relative molecular protein mass on four methods for total protein determination in urine. Pathology 22:89–92
Hemmingsen I, Skaarup P (1985) β2–Microglobulin in urine and serum determined by ELISA technique. Scand J Clin Invest 45:367–371
Price RG (1982) Urinary enzymes, nephrotoxicity and renal disease. Toxicology 23:99–134
Kunin CM, Chesney RW, Craig WA, England AC, De Angelis C (1978) Enzymuria as a marker of renal injury and disease: studies of N–acetyl–β–glucosaminidase in the general population and in patients with renal disease. Pediatrics 62:751–760
Guder WG, Hofmann W (1992) Markers for the diagnosis and monitoring of renal tubular lesions. Clin Nephrol 38 [Suppl 1]:S3–S7
Portman RJ, Kissane JM, Robson AM (1986) Use of β2 microglobulin to diagnose tubulo–interstitial renal lesions in children. Kidney Int 30:91–98
Tomlinson PA (1992) Low molecular weight proteins in children with renal disease. Pediatr Nephrol 6:565–571
Piscator M (1989) Markers of tubular dysfunction. Toxicol Lett 46:197–204
Michelakakis H, Dimitriou E, Georgakis H, Karabatsos F, Fragodimitri C, Saraphidou J, Premetis E, Karagiorga–Lagana M (1997) Iron overload and urinary lysosomal enzyme levels in beta–thalassemia major. Eur J Pediatr 156:602–604
Aldudak B, Karabay Bayazit A, Noyan A, özel A, Anarat A Sasmaz I, KilinÇ Y, Gali E, Anarat R, Dikmen N (2000) Renal function in pediatric patients with β–thalassemia major. Pediatr Nephrol 15:109–112
Shinar E, Rachmilewitz EA (1990) Oxidative denaturation of red blood cells in thalassemia. Semin Hematol 27:70–82
Hebble RP (1985) Auto-oxidation and a membrane-associated "Fenton reagent": a possible explanation for development of membrane lesions in sickle erythrocytes. Clin Haematol 14:129–140
Boyce NW, Holdsworth SR (1986) Hydroxyl radical mediation of immune renal injury by desferrioxamine. Kidney Int 30:813–817
Acknowledgement.
This study was funded by the Siriraj Grant for Research Development and Medical Education, Siriraj Hospital, Thailand (grant no. 75–348–292). P. Malasit is a recipient of the Senior Scholar Grant from the Thailand Research Fund. The Medical Molecular Biology Laboratory also operates as the Medical Biotechnology Unit funded by the National Center for Genetic Engineering (BIOTEC) of the National Science and Technology Development Agency (NSTDA), Thailand.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Sumboonnanonda, A., Malasit, P., Tanphaichitr, V.S. et al. Renal tubular dysfunction in α-thalassemia. Pediatr Nephrol 18, 257–260 (2003). https://doi.org/10.1007/s00467-003-1067-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00467-003-1067-7